ANNE VANLENT Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ANNE VANLENT.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ANNE VANLENT. ANNE VANLENT is Director in I STAT CORPORATION /DE/ ($STAT) and Director in Aviragen Therapeutics, Inc. ($NABI) and Director in QLT INC/BC ($QLTI) and Director in Onconova Therapeutics, Inc. ($ONTX) and Director in APPLIED GENETIC TECHNOLOGIES CORP ($AGTC) and Director in Ocera Therapeutics, Inc. ($TZYM) and Director in Aegerion Pharmaceuticals, Inc. ($AEGR) and Director in Trevi Therapeutics, Inc. ($TRVI).

Latest Insider Trading Transactions of ANNE VANLENT

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AEGR, AGTC, STAT, NVLN, TZYM, ONTX, TRVI, VXRT

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 18 2020AGTCAPPLIED GENETIC TE ...VANLENT ANNEDirectorOption ExerciseA4.7212,00056,64012,000
Jun 15 2020TRVITrevi Therapeutics ...VANLENT ANNEDirectorOption ExerciseA4.1014,21058,26114,210
Dec 06 2019AGTCAPPLIED GENETIC TE ...VANLENT ANNEDirectorOption ExerciseA3.0210,00030,20010,000
Jun 14 2019AVIRVaxart, Inc.VANLENT ANNEDirectorOption ExerciseA0.6812,7008,63612,700
Jun 14 2019AVIRVaxart, Inc.VANLENT ANNEDirectorOption ExerciseA0.689,0006,1209,000
May 13 2019TRVITrevi Therapeutics ...VANLENT ANNEDirectorOption ExerciseC0.0047,80700
May 13 2019TRVITrevi Therapeutics ...VANLENT ANNEDirectorOption ExerciseC0.00107,97700
May 13 2019TRVITrevi Therapeutics ...VANLENT ANNEDirectorBuyP10.005,00050,00025,98321 K to 26 K (+23.83 %)
May 13 2019TRVITrevi Therapeutics ...VANLENT ANNEDirectorBuyC0.0020,983020,9830 to 21 K
May 08 2019TRVITrevi Therapeutics ...VANLENT ANNEDirectorOption ExerciseA10.0023,684236,84023,684
Nov 19 2018AGTCAPPLIED GENETIC TE ...VANLENT ANNEDirectorOption ExerciseA6.9010,00069,00010,000
Jul 27 2018AGTCAPPLIED GENETIC TE ...VANLENT ANNEDirectorOption ExerciseA4.258,00034,0008,000
Dec 11 2017TZYMOcera Therapeutics ...VANLENT ANNEDirectorOption ExerciseD7.8410,00078,4000
Dec 11 2017TZYMOcera Therapeutics ...VANLENT ANNEDirectorOption ExerciseD50.882,652134,9340
Dec 11 2017TZYMOcera Therapeutics ...VANLENT ANNEDirectorOption ExerciseD48.002,08399,9840
Dec 11 2017TZYMOcera Therapeutics ...VANLENT ANNEDirectorOption ExerciseD3.7610,00037,6000
Dec 11 2017TZYMOcera Therapeutics ...VANLENT ANNEDirectorOption ExerciseD7.8520,000157,0000
Dec 11 2017TZYMOcera Therapeutics ...VANLENT ANNEDirectorOption ExerciseD2.2612,50028,2500
Dec 11 2017TZYMOcera Therapeutics ...VANLENT ANNEDirectorSellD1.5212,50019,000012.5 K to 0 (-100.00 %)
Jun 22 2017TZYMOcera Therapeutics ...VANLENT ANNEDirectorGrantA0.0012,500012,5000 to 12.5 K
May 22 2017AVIRAviragen Therapeut ...VANLENT ANNEDirectorOption ExerciseA0.4920,0009,800105,000
Mar 02 2017AGTCAPPLIED GENETIC TE ...VANLENT ANNEDirectorOption ExerciseA7.758,00062,0008,000
Dec 27 2016QLTINOVELION THERAPEUT ...VANLENT ANNEDirectorOption ExerciseA8.659,60083,0409,600
Dec 01 2016QLTIQLT INC/BCVANLENT ANNEDirectorGrantA0.004,10204,1020 to 4.1 K
Nov 30 2016AEGRAegerion Pharmaceu ...VANLENT ANNEDirectorOption ExerciseD17.9818,000323,6400
Nov 30 2016AEGRAegerion Pharmaceu ...VANLENT ANNEDirectorOption ExerciseD32.555,012163,1410
Nov 30 2016AEGRAegerion Pharmaceu ...VANLENT ANNEDirectorOption ExerciseD37.6614,700553,6020
Nov 30 2016AEGRAegerion Pharmaceu ...VANLENT ANNEDirectorSellD0.004,000004 K to 0 (-100.00 %)
Aug 18 2016AGTCAPPLIED GENETIC TE ...VANLENT ANNEDirectorOption ExerciseA15.1316,000242,08016,000
Jun 15 2016TZYMOcera Therapeutics ...VANLENT ANNEDirectorOption ExerciseA2.2612,50028,25012,500
May 13 2016NABIAviragen Therapeut ...VANLENT ANNEDirectorOption ExerciseA1.5020,00030,00020,000
Aug 13 2015NABIAviragen Therapeut ...VANLENT ANNEDirectorOption ExerciseA2.495,00012,4505,000
Jun 29 2015AEGRAegerion Pharmaceu ...VANLENT ANNEDirectorOption ExerciseA17.9818,000323,64018,000
Jun 24 2015NABIAviragen Therapeut ...VANLENT ANNEDirectorBuyP2.2035,00076,89235,0000 to 35 K
Jun 22 2015TZYMOcera Therapeutics ...VANLENT ANNEDirectorOption ExerciseA3.7610,00037,60010,000
Jun 17 2015ONTXOnconova Therapeut ...VANLENT ANNEDirectorOption ExerciseA2.6910,00026,90010,000
May 14 2015NABIAviragen Therapeut ...VANLENT ANNEDirectorOption ExerciseA2.2015,00033,00015,000
Jan 30 2004STATI STAT CORPORATION ...VANLENT ANNEDirectorOption ExerciseM6.596,23041,0560
Jan 30 2004STATI STAT CORPORATION ...VANLENT ANNEDirectorOption ExerciseM5.0810,25652,1000
Jan 30 2004STATI STAT CORPORATION ...VANLENT ANNEDirectorOption ExerciseM13.003,73748,5810
Jan 30 2004STATI STAT CORPORATION ...VANLENT ANNEDirectorOption ExerciseM9.754,87647,5410
Jan 30 2004STATI STAT CORPORATION ...VANLENT ANNEDirectorSellU15.356,23095,63106.2 K to 0 (-100.00 %)
Jan 30 2004STATI STAT CORPORATION ...VANLENT ANNEDirectorBuyM6.596,23041,0566,2300 to 6.2 K
Jan 30 2004STATI STAT CORPORATION ...VANLENT ANNEDirectorSellU15.3510,256157,430010.3 K to 0 (-100.00 %)
Jan 30 2004STATI STAT CORPORATION ...VANLENT ANNEDirectorBuyM5.0810,25652,10010,2560 to 10.3 K
Jan 30 2004STATI STAT CORPORATION ...VANLENT ANNEDirectorSellU15.353,73757,36303.7 K to 0 (-100.00 %)
Jan 30 2004STATI STAT CORPORATION ...VANLENT ANNEDirectorBuyM13.003,73748,5813,7370 to 3.7 K
Jan 30 2004STATI STAT CORPORATION ...VANLENT ANNEDirectorSellU15.354,87674,84704.9 K to 0 (-100.00 %)
Jan 30 2004STATI STAT CORPORATION ...VANLENT ANNEDirectorBuyM9.754,87647,5414,8760 to 4.9 K
Jan 30 2004STATI STAT CORPORATION ...VANLENT ANNEDirectorSellU15.3519,264295,702019.3 K to 0 (-100.00 %)

Page:   1